The immune boosting benefits of a tuberculosis vaccine can be seen in infants more than one year after vaccination, according to a new study. The research, led by the Murdoch Children’s Research Institute (MCRI) and published in Science Advances, has shown how the BCG vaccine, developed to prevent the risk of tuberculosis, can produce a […]
Rapid biomarker diagnostics for Cancers and heart disease: Imperial researchers have built a new easy-to-use test that could diagnose non-infectious diseases like heart attacks and cancers more quickly. The new test works by detecting molecular signals in the body called biomarkers, which are already used in things like COVID-19 testing where the presence of SARS-CoV-2 […]
Read More… from Rapid biomarker diagnostics for Cancers and heart disease
Joint statement by UNICEF Executive Director Catherine Russell and WHO Director-General Dr Tedros Adhanom Ghebreyesus on the occasion of World Breastfeeding Week: As global crises continue to threaten the health and nutrition of millions of babies and children, the vital importance of breastfeeding as the best possible start in life is more critical than ever. […]
A needle-free vaccine patch could better fight COVID-19 variants, such as Omicron and Delta, than a traditional needle vaccine according to a University of Queensland study in mice. The research, conducted in partnership with Brisbane biotechnology company Vaxxas, tested the Hexapro SARS-CoV-2 spike vaccine using the Vaxxas high-density microarray patch (HD-MAP) technology, and the results […]
Read More… from COVID vaccine patch fights variants better then needles
Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, six months after second doses, study finds. Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health record data on over seven million adults. Reassuringly, the […]
Read More… from Protection still high six months after second dose
Parasites that cause severe diarrhoea are likely to become more virulent because of the speed at which they are exchanging their DNA and evolving – according to new research from the University of East Anglia. Researchers studied the genomes of Cryptosporidium parvum – a zoonotic parasite that causes severe diarrhoea in both humans and animals. They found […]
Read More… from How globalisation could be making human parasites more virulent
A major review into childhood pneumonia by researchers from the Murdoch Children’s Research Institute (MCRI) and the University of Melbourne will inform new World Health Organization (WHO) guidelines to better manage the deadly infection. The research team led by Dr Hamish Graham, Dr Claire von Mollendorf and Professor Kim Mulholland, were commissioned by the WHO to lead several systematic reviews to help inform updated pneumonia […]
Read More… from New WHO guidelines to better treat and manage childhood pneumonia
Interrupting treatment of immune-suppressing medicines, doubles antibody response to COVID-19 booster vaccination: A major clinical trial, led by experts at the University of Nottingham working in partnership with several Universities and NHS hospitals, has found that by interrupting the treatment of vulnerable people on long-term immune supressing medicines for two weeks after a COVID-19 booster […]
Read More… from Immune-suppressing drugs and booster vaccination
People infected with the Omicron variant show poor immune boosting against future SARS-CoV-2 infection. These are the findings of a study published in the journal Science https://www.science.org/doi/10.1126/science.abq1841), led by researchers at Imperial College London, which looks at how the complex patchwork of immunity in the population following vaccination and previous infection influences our future protection […]
Read More… from Omicron infection is a poor booster of immunity
Potential for Mugwort allergy vaccine: Researchers have discovered key mechanisms of allergy to pollen from the common weed mugwort, thereby also laying the foundation for the development of the world’s first vaccine. Mugwort (Artemisia vulgaris) poses a serious problem for allergic individuals in our latitudes from July through to September. Currently, the symptoms, which often […]